(Total Views: 586)
Posted On: 12/22/2020 4:09:53 PM
Post# of 716
Ocugen (OCGN), a US biopharmaceutical company, said on Tuesday that it is teaming up with India's Bharat Biotech to co-develop Bharat's COVID-19 vaccine candidate, Covaxin, for the US market.
Covaxin is a whole-virion inactivated COVID-19 vaccine candidate. It has been evaluated in 1,000 subjects in early stage and mid-stage clinical trials in India, with promising safety and immunogenicity data, the companies said. The vaccine candidate is currently part of a late-stage clinical trial in India involving 26,000 volunteers.
Shares of Ocugen surged more than 59% in morning trading.
Price: 0.47, Change: +0.17, Percent Change: +59.12
HOD .8375
Covaxin is a whole-virion inactivated COVID-19 vaccine candidate. It has been evaluated in 1,000 subjects in early stage and mid-stage clinical trials in India, with promising safety and immunogenicity data, the companies said. The vaccine candidate is currently part of a late-stage clinical trial in India involving 26,000 volunteers.
Shares of Ocugen surged more than 59% in morning trading.
Price: 0.47, Change: +0.17, Percent Change: +59.12
HOD .8375
(0)
(0)
The majority of my post are the top 20% gainer! To decode them its (ticker ID, % Changed, Volume, Close price and Float) I typically put V,C&F as a prefix to that number and use K, M and B as a suffix (Kilo, Million & Billion) for volume and float. I may also use S for Support and R for Resistance.
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
I (Znewcar1) do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
